Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00653068 · OUTCOME

Toxic Death

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System · Source last updated 2024-04-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
During and after completion of study treatment up to 1 year after enrollment.

What was measured

The number of patients who experience death that is considered to be primarily attributable to complications of treatment.

Analysis population: One patient was ineligible in stratum I and one patient was ineligible in stratum III. There were no patients enrolled in Stratum 2 or 4.

Groups in this outcome

Stratum I

Infants (\<36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.

Stratum III

Older children (greater than 36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Stratum I57
Stratum III11

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Stratum I3Not reportedNot reportedNot reportedNot reported
Stratum III1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        1
denoms
  1. counts
    1. group Id
      OG000
      value
      57
    2. group Id
      OG001
      value
      11
    units
    Participants
description
The number of patients who experience death that is considered to be primarily attributable to complications of treatment.
groups
  1. description
    Infants (\<36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.
    id
    OG000
    title
    Stratum I
  2. description
    Older children (greater than 36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.
    id
    OG001
    title
    Stratum III
param Type
COUNT_OF_PARTICIPANTS
population Description
One patient was ineligible in stratum I and one patient was ineligible in stratum III. There were no patients enrolled in Stratum 2 or 4.
reporting Status
POSTED
time Frame
During and after completion of study treatment up to 1 year after enrollment.
title
Toxic Death
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice